Admetsys: Real-Time Remote Monitoring of Blood Glucose Levels for Diabetic Patients, Physicians, Clinicians & Health Advocates
Smartphone, Tablet & Desktop Application for Real-Time Monitoring of Diabetic Patient Blood Glucose Levels
Diabetes impacts the quality of life of over 30 million Americans with an additional 89 million Americas borderline diabetic or prediabetic. Diabetics are 4x more likely to be hospitalized and diabetes is the leading cause of cardiovascular, blindness and lower-body amputations. For effected individuals, well-controlled blood glucose levels are critical to preventing cardiac issues, retinopathy and other complications.
Further, diabetes is the fastest-growing cause of inpatient and surgical care costs in the world. US spending on diagnosed diabetic care already exceeds $245 billion annually, with 43% of these costs coming from hospital care. Today, over 40% of patients admitted to hospital are now at diabetic risk. Despite this, techniques for controlling glucose levels in hospitalized patients have remained unchanged for nearly three decades, and are too imprecise, labor-intensive, and coarsely implemented to address the growing need.
Admetsys has developed a first-of-its-kind patient remote monitoring platform for glucose levels. Patients, physicians and clinicians can use the tool to monitor blood sugar levels remotely via a smartphone, tablet or desktop computer. Proactive management of blood sugar levels is important as it improves health economics and patient outcomes including minimizing readmissions. Proper control of blood glucose levels and avoidance of harmful low levels saves lives (34% mortality reduction), decreases complications (by 40–50% over numerous co-morbidities), and speeds recovery (by 1.8 days in critical care patients). Foremost, this is a fundamental standard of care issue, increasingly cited by regulatory and standards bodies. Understanding of this need is becoming a key financial driver for hospitals as well, with impact both on revenue (from outcome-based reimbursement) and cost savings (independently shown to be $7,500+ per patient).
This technology is a direct answer to both a desperate medical need and demonstrated market demand. The relentless rise of diabetes is fundementally altering the demographics of hospital care. To meet the challenge of providing proper care to all in need, hospitals are clamoring for tools that are safer, more precise, and more cost effective.